| Total Revenues (Q4 2025) | $8.4 million | CFO |
| Total Revenues (Q4 2024) | $14.6 million | CFO |
| Product Revenues (Q4 2025) | $5.6 million | CFO |
| Product Revenues (Q4 2024) | $12.6 million | CFO |
| Non-Product Revenues (Q4 2025) | $2.5 million | CFO |
| Non-Product Revenues (Q4 2024) | $1.7 million | CFO |
| Cost of Product Revenue as % of Net Product Revenue (Q4 2025) | 83% | CFO |
| Cost of Product Revenue as % of Net Product Revenue (Q4 2024) | 84% | CFO |
| R&D Expense (Q4 2025) | $3.5 million | CFO |
| R&D Expense (Q4 2024) | $3.2 million | CFO |
| SG&A (Q4 2025) | $4.5 million | CFO |
| SG&A (Q4 2024) | $3.1 million | CFO |
| Cash and Cash Equivalents (Dec 27, 2025) | $37.8 million | CFO |
| Capital Raised in 2025 | $56 million | CEO |
| FY 2026 Revenue Guidance | $52 million – $60 million | CEO |